Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 30280641

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2018 Dec 6
First author
Horn L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Dec;15(12):725. doi: 10.1038/s41571-018-0109-9.
    note
    Source null
    related pmid
    30279453
    relationship
    Comment in
  2. citation
    Cancer Discov. 2018 Dec;8(12):OF10. doi: 10.1158/2159-8290.CD-NB2018-133.
    note
    Source null
    related pmid
    30305284
    relationship
    Comment in
  3. citation
    Ann Transl Med. 2018 Dec;6(Suppl 2):S120. doi: 10.21037/atm.2018.12.25.
    note
    Source null
    related pmid
    30740441
    relationship
    Comment in
  4. citation
    N Engl J Med. 2019 Feb 28;380(9):888-889. doi: 10.1056/NEJMc1900123.
    note
    Source null
    related pmid
    30811920
    relationship
    Comment in
  5. citation
    N Engl J Med. 2019 Feb 28;380(9):889. doi: 10.1056/NEJMc1900123.
    note
    Source null
    related pmid
    30811921
    relationship
    Comment in
  6. citation
    N Engl J Med. 2019 Feb 28;380(9):889-890. doi: 10.1056/NEJMc1900123.
    note
    Source null
    related pmid
    30811922
    relationship
    Comment in

Authors and identifiers

  1. name
    Horn L
    type
    Author
  2. name
    Mansfield AS
    type
    Author
  3. name
    Szczęsna A
    type
    Author
  4. name
    Havel L
    type
    Author
  5. name
    Krzakowski M
    type
    Author
  6. name
    Hochmair MJ
    type
    Author
  7. name
    Huemer F
    type
    Author
  8. name
    Losonczy G
    type
    Author
  9. name
    Johnson ML
    type
    Author
  10. name
    Nishio M
    type
    Author
  11. name
    Reck M
    type
    Author
  12. name
    Mok T
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Horn L
    type
    Author
  2. name
    Mansfield AS
    type
    Author
  3. name
    Szczęsna A
    type
    Author
  4. name
    Havel L
    type
    Author
  5. name
    Krzakowski M
    type
    Author
  6. name
    Hochmair MJ
    type
    Author
  7. name
    Huemer F
    type
    Author
  8. name
    Losonczy G
    type
    Author
  9. name
    Johnson ML
    type
    Author
  10. name
    Nishio M
    type
    Author
  11. name
    Reck M
    type
    Author
  12. name
    Mok T
    type
    Author
bibliography ids
  1. nci-bib-2377fc3e7c83e2e1df8b0002
book metadata
content sha256
a91b69a1976575dcde8fe478d39790c512cf63378704e93c605a0aa513d3cd6a
document type
citation
dois
  1. 10.1056/NEJMoa1809064
electronic publication date
display
2018 Sep 25
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:30280641
immutable id
pubmed:30280641@a91b69a1976575dcde8fe478d39790c512cf63378704e93c605a0aa513d3cd6a
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
23
name
The New England journal of medicine
nlm unique id
0255562
pages
2220-2229
volume
379
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Dec;15(12):725. doi: 10.1038/s41571-018-0109-9.
    note
    Source null
    related pmid
    30279453
    relationship
    Comment in
  2. citation
    Cancer Discov. 2018 Dec;8(12):OF10. doi: 10.1158/2159-8290.CD-NB2018-133.
    note
    Source null
    related pmid
    30305284
    relationship
    Comment in
  3. citation
    Ann Transl Med. 2018 Dec;6(Suppl 2):S120. doi: 10.21037/atm.2018.12.25.
    note
    Source null
    related pmid
    30740441
    relationship
    Comment in
  4. citation
    N Engl J Med. 2019 Feb 28;380(9):888-889. doi: 10.1056/NEJMc1900123.
    note
    Source null
    related pmid
    30811920
    relationship
    Comment in
  5. citation
    N Engl J Med. 2019 Feb 28;380(9):889. doi: 10.1056/NEJMc1900123.
    note
    Source null
    related pmid
    30811921
    relationship
    Comment in
  6. citation
    N Engl J Med. 2019 Feb 28;380(9):889-890. doi: 10.1056/NEJMc1900123.
    note
    Source null
    related pmid
    30811922
    relationship
    Comment in
outcomes validated
false
pmid
30280641
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
80ef9d3c00939d2414751ab96e7e4d274ae5a51f40562db623ec5642907a3895
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2018 Dec 6
precision
day
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30280641/
title
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.

Preserved source evidence · Independent clinical review pending · Not medical advice